{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:24:21Z","timestamp":1747207461877,"version":"3.40.5"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p\/>\n<\/jats:sec>","DOI":"10.2174\/1574886318666230409145228","type":"journal-article","created":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T11:16:01Z","timestamp":1681038961000},"page":"3-7","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Safety and Effectiveness of Antifungal Medications in the Management\nof Mucormycosis during the COVID-19 Pandemic"],"prefix":"10.2174","volume":"19","author":[{"given":"Dhanya","family":"Jose","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Goa Medical College, Goa, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna S.","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of General Medicine, P.S.G.\nHospitals &amp; Research Center, Coimbatore, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Alagesan","sequence":"additional","affiliation":[{"name":"Department of General Medicine, P.S.G.\nHospitals &amp; Research Center, Coimbatore, Tamil Nadu, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-5255","authenticated-orcid":true,"given":"Joseph M.","family":"Pappachan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology &amp; Metabolism, Lancashire\nTeaching Hospitals NHS Trust, Preston, UK"},{"name":"Faculty of Science, Manchester Metropolitan University, All Saints\nBuilding, Manchester, M15 6BH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e0009921","DOI":"10.1371\/journal.pntd.0009921","volume":"15","author":"Aranjani J.M.","year":"2021","unstructured":"Aranjani J.M.; Manuel A.; Abdul Razack H.I.; Mathew S.T.; COVID-19\u2013associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic\u2019s second wave in India. PLoS Negl Trop Dis 2021,15(11),e0009921","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"20499361211027065","DOI":"10.1177\/20499361211027065","volume":"8","author":"Rodriguez-Morales A.J.","year":"2021","unstructured":"Rodriguez-Morales A.J.; Sah R.; Millan-O\u00f1ate J.; COVID-19 associated mucormycosis: The urgent need to reconsider the indiscriminate use of immunosuppressive drugs. Ther Adv Infect Dis 2021,8,20499361211027065","journal-title":"Ther Adv Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","volume":"26","author":"Patel A.","year":"2020","unstructured":"Patel A.; Kaur H.; Xess I.; A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect 2020,26(7),944.e9-944.e15","journal-title":"Clin Microbiol Infect"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e0251170","DOI":"10.1371\/journal.pone.0251170","volume":"16","author":"Musuuza J.S.","year":"2021","unstructured":"Musuuza J.S.; Watson L.; Parmasad V.; Putman-Buehler N.; Christensen L.; Safdar N.; Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS One 2021,16(5),e0251170","journal-title":"PLoS One"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.mycmed.2021.101161","volume":"31","author":"Suvvari T.K.","year":"2021","unstructured":"Suvvari T.K.; Arigapudi N.; Kandi V.R.; Kutikuppala L.V.S.; Mucormycosis: A killer in the shadow of COVID-19. J Mycol Med 2021,31(3),101161","journal-title":"J Mycol Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1093\/mmy\/myx101","volume":"56","author":"Skiada A.","year":"2018","unstructured":"Skiada A.; Lass-Floerl C.; Klimko N.; Ibrahim A.; Roilides E.; Petrikkos G.; Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 2018,56(Suppl. 1),S93-S101","journal-title":"Med Mycol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"Cornely O.A.","year":"2019","unstructured":"Cornely O.A.; Alastruey-Izquierdo A.; Arenz D.; Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019,19(12),e405-e421","journal-title":"Lancet Infect Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1060028016655425","volume":"50","author":"Riley T.T.","year":"2016","unstructured":"Riley T.T.; Muzny C.A.; Swiatlo E.; Legendre D.P.; Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. Ann Pharmacother 2016,50(9),747-757","journal-title":"Ann Pharmacother"},{"key":"ref=9","unstructured":"Directorate General Of Health Services, Ministry of Health and Family Welfare, Government of India. National leprosy Eradication program. Available from:"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"Stone N.R.H.","year":"2016","unstructured":"Stone N.R.H.; Bicanic T.; Salim R.; Hope W.; Liposomal Amphotericin B (AmBisome\u00ae): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs 2016,76(4),485-500","journal-title":"Drugs"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(10)70316-9","volume":"11","author":"Sun H.Y.","year":"2011","unstructured":"Sun H.Y.; Singh N.; Mucormycosis: Its contemporary face and management strategies. Lancet Infect Dis 2011,11(4),301-311","journal-title":"Lancet Infect Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"Laniado-Labor\u00edn R.","year":"2009","unstructured":"Laniado-Labor\u00edn R.; Cabrales-Vargas M.N.; Amphotericin B.; Side effects and toxicity. Rev Iberoam Micol 2009,26(4),223-227","journal-title":"Rev Iberoam Micol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/myc.13100","volume":"63","author":"Yoshida I.","year":"2020","unstructured":"Yoshida I.; Saito A.M.; Tanaka S.; Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever. Mycoses 2020,63(8),794-801","journal-title":"Mycoses"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jof4030090","volume":"4","author":"Sipsas N.V.","year":"2018","unstructured":"Sipsas N.V.; Gamaletsou M.N.; Anastasopoulou A.; Kontoyiannis D.P.; Therapy of mucormycosis. J Fungi 2018,4(3),90","journal-title":"J Fungi"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","volume":"118","author":"Kontoyiannis D.P.","year":"2011","unstructured":"Kontoyiannis D.P.; Lewis R.E.; How I treat mucormycosis. Blood 2011,118(5),1216-1224","journal-title":"Blood"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2006.01295.x","volume":"49","author":"Hof H.","year":"2006","unstructured":"Hof H.; A new, broad-spectrum azole antifungal: Posaconazole? mechanisms of action and resistance, spectrum of activity. Mycoses 2006,49(S1),2-6","journal-title":"Mycoses"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s43162-022-00143-7","volume":"34","author":"Gogineni H.","year":"2022","unstructured":"Gogineni H.; So W.; Mata K.; Greene J.N.; Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: A description of current reports. Egypt J Intern Med 2022,34(1),58","journal-title":"Egypt J Intern Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/jof6040324","volume":"6","author":"Ellsworth M.","year":"2020","unstructured":"Ellsworth M.; Ostrosky-Zeichner L.; Isavuconazole: Mechanism of action, clinical efficacy, and resistance. J Fungi 2020,6(4),324","journal-title":"J Fungi"},{"key":"ref=19","first-page":"11","volume":"69","author":"Pal P.","year":"2021","unstructured":"Pal P.; Chatterjee N.; Ghosh S.; COVID associated mucormycosis: A study on the spectrum of clinical, biochemical and radiological findings in A series of ten patients. J Assoc Physicians India 2021,69(10),11-12","journal-title":"J Assoc Physicians India"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/am.am_86_22","volume":"19","author":"Bavadiya B.","year":"2022","unstructured":"Bavadiya B.; Bhatt J.; Deshpande S.; Mehta K.; Raj R.; Liver and renal function profile of mucormycosis cases receiving amphotericin B - A retrospective study. Apollo Medicine 2022,19,208-212","journal-title":"Apollo Medicine"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.jinf.2004.11.002","volume":"51","author":"Garbino J.","year":"2005","unstructured":"Garbino J.; U\u00e7kay I.; Amini K.; Puppo M.; Richter M.; Lew D.; Absidia posttraumatic infection: Successful treatment with posaconazole. J Infect 2005,51(3),e135-e138","journal-title":"J Infect"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/jof7100837","volume":"7","author":"Riad A.","year":"2021","unstructured":"Riad A.; Shabaan A.A.; Issa J.; COVID-19-associated mucormycosis (CAM): Case-series and global analysis of mortality risk factors. J Fungi 2021,7(10),837","journal-title":"J Fungi"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/myc.13338","volume":"64","author":"Pal R.","year":"2021","unstructured":"Pal R.; Singh B.; Bhadada S.K.; COVID\u201019\u2010associated mucormycosis: An updated systematic review of literature. Mycoses 2021,64(12),1452-1459","journal-title":"Mycoses"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.3324\/haematol.2012.083063","volume":"98","author":"Pagano L.","year":"2013","unstructured":"Pagano L.; Cornely O.A.; Busca A.; Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: A report from the Seifem and Fungiscope registries. Haematologica 2013,98(10),e127-e130","journal-title":"Haematologica"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","volume":"50","author":"Greenberg R.N.","year":"2006","unstructured":"Greenberg R.N.; Mullane K.; van Burik J.A.H.; Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006,50(1),126-133","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"Roden M.M.","year":"2005","unstructured":"Roden M.M.; Zaoutis T.E.; Buchanan W.L.; Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005,41(5),634-653","journal-title":"Clin Infect Dis"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230409145228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215567\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230409145228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T12:37:32Z","timestamp":1701693452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215567\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886318666230409145228","relation":{},"ISSN":["1574-8863"],"issn-type":[{"type":"print","value":"1574-8863"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}